Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Jennifer L Oliver

TitleSenior Instructor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, Hitchings B, Diamond D, Thomas AC, Mitchell RE, Kibble M, Gupta K, Di Bartolo N, Klenerman P, Brown A, Morales-Aza B, Oliver J, Berger I, Toye AM, Finn A, Goenka A, Davidson AD, Ring S, Molloy L, Lewcock M, Northstone K, Roth F, Timpson NJ, Wooldridge L, Halliday A, Rivino L. Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. J Infect Dis. 2025 May 20. PMID: 40392230.
      View in: PubMed
    2. Hyams C, Challen R, Lahuerta M, Begier E, McGuinness S, Clout M, Southern J, Campling J, Oliver J, Theilacker C, Ellsbury G, Maskell N, Gessner BD, Danon L, Finn A. Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023. BMJ Open Respir Res. 2025 May 16; 12(1). PMID: 40379263.
      View in: PubMed
    3. Duncan P, Mears R, Begier E, Rouhbakhsh Halvaei S, Southern J, Porter SB, Hubler R, Oben G, Qian G, Lahuerta M, Davis T, Campling J, Dawson S, Christensen H, Oliver J, Morales-Aza B, Pan K, Gray S, Hyams C, Danon L, Gessner BD, Finn A, Hay AD. Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2). BJGP Open. 2024 Dec; 8(4). PMID: 39251234.
      View in: PubMed
    4. Chatzilena A, Hyams C, Challen R, Marlow R, King J, McGuinness S, Maskell N, Oliver J, Finn A, Danon L. Winter 2022-23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study. Vaccine. 2024 Oct 03; 42(23):126073. PMID: 38918104.
      View in: PubMed
    5. Kwiatkowska R, Chatzilena A, King J, Clout M, McGuinness S, Maskell N, Oliver J, Challen R, Hickman M, Finn A, Hyams C, Danon L. Syndromic case definitions for lower respiratory tract infection (LRTI) are less sensitive in older age: an analysis of symptoms among hospitalised adults. BMC Infect Dis. 2024 Jun 07; 24(1):568. PMID: 38849730.
      View in: PubMed
    6. Hyams C, Lahuerta M, Theilacker C, King J, Adegbite D, McGuinness S, Grimes C, Campling J, Southern J, Pride MW, Begier E, Maskell N, Oliver J, Jodar L, Gessner BD, Finn A. Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK. Vaccine. 2024 Mar 07; 42(7):1599-1607. PMID: 38336560.
      View in: PubMed
    7. Hathaway A, Qian G, King J, McGuinness S, Maskell N, Oliver J, Finn A, Danon L, Challen R, Toye AM, Hyams C. Association of ABO and Rhesus blood groups with severe outcomes from non-SARS-CoV-2 respiratory infection: A prospective observational cohort study in Bristol, UK 2020-2022. Br J Haematol. 2024 Mar; 204(3):826-838. PMID: 38009561.
      View in: PubMed
    8. Chatzilena A, Hyams C, Challen R, Marlow R, King J, Adegbite D, Kinney J, Clout M, Maskell N, Oliver J, Finn A, Danon L. Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022. Euro Surveill. 2023 11; 28(48). PMID: 38037728.
      View in: PubMed
    9. Hyams C, Qian G, Nava G, Challen R, Begier E, Southern J, Lahuerta M, Nguyen JL, King J, Morley A, Clout M, Maskell N, Jodar L, Oliver J, Ellsbury G, McLaughlin JM, Gessner BD, Finn A, Danon L, Dodd JW. Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults. J R Soc Med. 2023 11; 116(11):371-385. PMID: 37404021.
      View in: PubMed
    10. Marlow R, Roderick M, Oliver J, Jordan Z, Amirthalingam G, Lopez-Bernal J, Finn A, Rodrigues F. Epidemiology of hospitalisations due to chickenpox and quality of life lost in community and hospital settings: protocol for a prospective cohort study across two countries. BMJ Open. 2023 03 29; 13(3):e068611. PMID: 36990479.
      View in: PubMed
    11. Thomas AC, Oliver E, Baum HE, Gupta K, Shelley KL, Long AE, Jones HE, Smith J, Hitchings B, di Bartolo N, Vasileiou K, Rabi F, Alamir H, Eghleilib M, Francis O, Oliver J, Morales-Aza B, Obst U, Shattock D, Barr R, Collingwood L, Duale K, Grace N, Livera GG, Bishop L, Downing H, Rodrigues F, Timpson N, Relton CL, Toye A, Woolfson DN, Berger I, Goenka A, Davidson AD, Gillespie KM, Williams AJK, Bailey M, Brooks-Pollock E, Finn A, Halliday A. Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults. Commun Med (Lond). 2023 Mar 15; 3(1):37. PMID: 36922542.
      View in: PubMed
    12. Hyams C, Challen R, Marlow R, Nguyen J, Begier E, Southern J, King J, Morley A, Kinney J, Clout M, Oliver J, Gray S, Ellsbury G, Maskell N, Jodar L, Gessner B, McLaughlin J, Danon L, Finn A. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom. Lancet Reg Health Eur. 2023 Feb; 25:100556. PMID: 36530491.
      View in: PubMed
    13. Chatzilena A, Hyams C, Challen R, Marlow R, King J, Adegbite D, Kinney J, Clout M, Maskell N, Oliver J, Danon L, Finn A. Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study. Lancet Reg Health Eur. 2023 Feb; 25:100552. PMID: 36506791.
      View in: PubMed
    14. Halliday A, Long AE, Baum HE, Thomas AC, Shelley KL, Oliver E, Gupta K, Francis O, Williamson MK, Di Bartolo N, Randell MJ, Ben-Khoud Y, Kelland I, Mortimer G, Ball O, Plumptre C, Chandler K, Obst U, Secchi M, Piemonti L, Lampasona V, Smith J, Gregorova M, Knezevic L, Metz J, Barr R, Morales-Aza B, Oliver J, Collingwood L, Hitchings B, Ring S, Wooldridge L, Rivino L, Timpson N, McKernon J, Muir P, Hamilton F, Arnold D, Woolfson DN, Goenka A, Davidson AD, Toye AM, Berger I, Bailey M, Gillespie KM, Williams AJK, Finn A. Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2. Front Immunol. 2022; 13:968317. PMID: 36439154.
      View in: PubMed
    15. Hyams C, Challen R, Begier E, Southern J, King J, Morley A, Szasz-Benczur Z, Gonzalez MG, Kinney J, Campling J, Gray S, Oliver J, Hubler R, Valluri S, Vyse A, McLaughlin JM, Ellsbury G, Maskell NA, Gessner BD, Danon L, Finn A. Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study. Lancet Reg Health Eur. 2022 Oct; 21:100473. PMID: 35965672.
      View in: PubMed
    16. Carr JP, MacLennan JM, Plested E, Bratcher HB, Harrison OB, Aley PK, Bray JE, Camara S, Rodrigues CMC, Davis K, Bartolf A, Baxter D, Cameron JC, Cunningham R, Faust SN, Fidler K, Gowda R, Heath PT, Hughes S, Khajuria S, Orr D, Raman M, Smith A, Turner DPJ, Whittaker E, Williams CJ, Zipitis CS, Pollard AJ, Oliver J, Morales-Aza B, Lekshmi A, Clark SA, Borrow R, Christensen H, Trotter C, Finn A, Maiden MC, Snape MD. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. Clin Microbiol Infect. 2022 Dec; 28(12):1649.e1-1649.e8. PMID: 35840033.
      View in: PubMed
    17. Hyams C, Begier E, Garcia Gonzalez M, Southern J, Campling J, Gray S, Oliver J, Gessner BD, Finn A. Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology. BMJ Open. 2022 06 15; 12(6):e057464. PMID: 35705333.
      View in: PubMed
    18. Hyams C, Marlow R, Maseko Z, King J, Ward L, Fox K, Heath R, Tuner A, Friedrich Z, Morrison L, Ruffino G, Antico R, Adegbite D, Szasz-Benczur Z, Garcia Gonzalez M, Oliver J, Danon L, Finn A. Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study. Lancet Infect Dis. 2021 11; 21(11):1539-1548. PMID: 34174190.
      View in: PubMed
    19. Oliver JL, Sadorge C, Boisnard F, Snape MD, Tomlinson R, Mann R, Rudd P, Bhakthavalsala S, Faust SN, Heath PT, Hughes SM, Borrow R, Thomas S, Finn A. Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series. Vaccine. 2020 07 31; 38(35):5718-5725. PMID: 32654902.
      View in: PubMed
    20. Rodrigues F, Christensen H, Morales-Aza B, Sikora P, Oliver E, Oliver J, Lucidarme J, Marlow R, Janu?rio L, Finn A. Viable Neisseria meningitidis is commonly present in saliva in healthy young adults: Non-invasive sampling and enhanced sensitivity of detection in a follow-up carriage study in Portuguese students. PLoS One. 2019; 14(2):e0209905. PMID: 30742640.
      View in: PubMed
    21. Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, Ladhani S, Okike IO, Oeser C, Kent A, Oliver J, Taylor P, Morales-Aza B, Clarke SC, Casey M, Martins F, Kitchin NR, Anderson AS, Jones H, Jansen KU, Eiden J, Pedneault L, Heath PT, Finn A, Faust SN, Pollard AJ. Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect. 2015 Jul; 71(1):43-52. PMID: 25709085.
      View in: PubMed
    22. Oliver JL, Pashmi G, Barnett P, Mettens P, Biemans R, Monteyne P, Palmantier R, Gallagher T, Ramaya S, Wonnacott S. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies. Vaccine. 2007 Oct 16; 25(42):7354-62. PMID: 17870213.
      View in: PubMed
    Oliver's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (86) concept(s)
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)